Table 1 Demographic, laboratory and clinical characteristics of study population
Patients characteristics | Mean | SD | Median | 25 - 75 P |
|---|---|---|---|---|
Age (years) | 53.40 | 11.78 | 54.00 | 45.00 - 62.00 |
Disease duration (years) | 5.13 | 4.95 | 4.00 | 2.00 - 7.00 |
ASDAS-ESR | 2.48 | 0.65 | 2.49 | 2.06 - 2.93 |
ASDAS-CPR | 2.56 | 0.77 | 2.53 | 2.04 - 3.13 |
SASDAS (0–10) | 20.18 | 7.33 | 20.10 | 14.30 - 25.82 |
BASDAI (0–10) | 4.10 | 1.48 | 4.00 | 3.15 - 5.12 |
 • BASDAI item 1: fatigue/tiredness | 6.00 | 2.34 | 6.00 | 4.00 - 8.00 |
 • BASDAI item 2: neck back or hip pain | 5.04 | 2.16 | 5.00 | 3.75 - 7.00 |
 • BASDAI item 3: pain and swelling in other joints | 4.88 | 2.65 | 5.00 | 3.00 - 7.00 |
 • BASDAI item 4: discomfort from areas tender to touch | 1.98 | 1.38 | 2.00 | 1.00 - 2.25 |
 • BASDAI item 5: level of morning stiffness | 3.73 | 1.83 | 3.50 | 2.50 - 5.00 |
 • BASDAI item 6: duration of morning stiffness | 3.61 | 2.24 | 3.00 | 2.00 - 5.00 |
BASFI (0–10) | 4.47 | 1.99 | 4.44 | 3.20 - 5.55 |
EQ-5D score (0–1) | 0.70 | 0.13 | 0.68 | 0.61 - 0.78 |
Patient’s global status (0–10) | 5.05 | 2.38 | 5.00 | 4.00 - 7.00 |
CRP level, mg/l | 9.19 | 9.28 | 6.10 | 3.30 - 11.44 |
ESR, mm/hour | 17.4 | 10.51 | 16.50 | 8.40 - 20.80 |